Medicare Enrolled

Dr. Andrew Seevaratnam, M.D

Internal Medicine · Ocala, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1834 SW 1ST AVE STE 101, Ocala, FL 34471
3527325552
In practice since 2008 (18 years)
NPI: 1891971271 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seevaratnam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seevaratnam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seevaratnam

Dr. Andrew Seevaratnam is an internal medicine specialist in Ocala, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Seevaratnam performed 2,898 Medicare services across 2,333 unique beneficiaries.

Between the years covered by Open Payments, Dr. Seevaratnam received a total of $44,931 from 50 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seevaratnam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 14% volume in FL $44,931 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 106564 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
2,898
Medicare services
Top 14% in FL for internal medicine
2,333
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~161 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Initial hospital admission, high complexity 437 $140 $264
Hospital follow-up visit, high complexity 380 $96 $181
Office visit, established patient (30-39 min) 372 $95 $190
Office visit, established patient (20-29 min) 328 $64 $137
Critical care, first 30-74 min 297 $174 $364
Hospital follow-up visit, moderate complexity 217 $64 $120
Test to measure expiratory airflow and volume changes before and after medication administration 173 $29 $88
Test to examine how well the lungs exchange gases 168 $43 $67
Test to determine lung volumes using gas dilution or washout 124 $34 $65
New patient office visit (45-59 min) 92 $128 $249
Irrigation and suction of lung airways to obtain cells using an endoscope 59 $64 $343
Test to determine lung volumes using sensors 48 $41 $65
Test for exercise-induced lung stress 35 $24 $60
New patient office visit, complex (60-74 min) 25 $170 $330
Sleep study including heart rate, breathing, airflow, and effort 22 $69 $300
Sleep study in sleep lab (6 years or older) 21 $450 $1,000
Biopsy of lobe of lung using an endoscope, 1 lobe 16 $74 $260
Smoking and tobacco use intensive counseling, 4-10 minutes 16 $15 $22
Computer-assisted image-guided navigation of lung airways using an endoscope 15 $78 $130
Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound 15 $54 $107
Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope 13 $150 $303
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 13 $29 $43
Insertion of non-tunneled central venous tube for infusion (5 years or older) 12 $69 $271
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
2.0% medium
97.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$44,931
Total received (2018-2024)
Avg $6,419/year across 7 years
Top 2% in FL for internal medicine
50
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34,781 (77.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,150 (22.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,096
2023
$7,785
2022
$13,133
2021
$11,328
2020
$8,346
2019
$1,680
2018
$1,562

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$33,246
Pinnacle Biologics, Inc
$2,472
AstraZeneca Pharmaceuticals LP
$1,601
Ethicon Inc.
$1,595
Boehringer Ingelheim Pharmaceuticals, Inc.
$969
Intuitive Surgical, Inc.
$570
GENZYME CORPORATION
$441
ABIOMED
$385
Grifols USA, LLC
$370
Takeda Pharmaceuticals U.S.A., Inc.
$297
Janssen Pharmaceuticals, Inc
$276
Electromed, Inc.
$233
Philips Electronics North America Corporation
$228
Genentech USA, Inc.
$199
Pulmonx Corporation
$194
Regeneron Healthcare Solutions, Inc.
$176
Mylan Specialty L.P.
$172
Sunovion Pharmaceuticals Inc.
$136
Allergan Inc.
$126
La Jolla Pharmaceutical Company
$119
Harmony Biosciences LLC
$103
Avadel CNS Pharmaceuticals, LLC
$95
Shire North American Group Inc
$85
Actelion Pharmaceuticals US, Inc.
$83
Insmed, Inc.
$82
Penumbra, Inc.
$66
Novartis Pharmaceuticals Corporation
$63
Alexion Pharmaceuticals, Inc.
$39
United Therapeutics Corporation
$38
Amgen Inc.
$35
JAZZ PHARMACEUTICALS INC.
$35
ANI Pharmaceuticals, Inc.
$35
Baxter Healthcare
$34
Merck Sharp & Dohme Corporation
$33
Fisher & Paykel Healthcare Inc
$32
PFIZER INC.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$27
Melinta Therapeutics, LLC
$24
Gilead Sciences, Inc.
$22
Inogen, Inc.
$19
Tactile Systems Technology Inc
$18
Boston Scientific Corporation
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
PORTOLA PHARMACEUTICALS, LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
Melinta Therapeutics, Inc.
$12
Nabriva Therapeutics, plc
$12
Breathe Technologies, Inc.
$11
Top 3 companies account for 83.1% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8874) inCourage · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Baxdela · CHANTIX · CHARTIS CATHETER · CINQAIR · DALVANCE · DUPIXENT · Da Vinci Surgical System · Dymista · EXALT Model D · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · Flexitouch Plus · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Impella · Indigo System · LIFE2000 · LONHALA MAGNAIR · LUMRYZ · LifeVest · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Perforomist · Photofrin · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Utibron · Vabomere · WAKIX · XARELTO · XOLAIR · Xenleta · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in FL.

Equivalent to $1,550 per 100 Medicare services performed
Looking for an internal medicine specialist in Ocala?
Compare internal medicine physicians in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
240
Per 100K population
61.9
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Seevaratnam is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), with speaking/promotional industry engagement in the top 2% of FL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Seevaratnam experienced with initial hospital admission, high complexity?
Based on Medicare claims data, Dr. Seevaratnam performed 437 initial hospital admission, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seevaratnam receive payments from pharmaceutical companies?
Yes. Dr. Seevaratnam received a total of $44,931 from 50 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seevaratnam's costs compare to other internal medicine physicians in Ocala?
Dr. Seevaratnam's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seevaratnam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →